EMMANUEL MINTAH MINTAH BONKU

Dr. EMMANUEL MINTAH MINTAH BONKU

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
EBEMMANUEL MINTAH MINTAH BONKU
EMMANUEL MINTAH MINTAH BONKU
HQHongjian Qin
Hongjian Qin
AOAbdullajon Odilov
Abdullajon Odilov
SASafomuddin Abduahadi
Safomuddin Abduahadi
SGSamuel Desta Guma
Samuel Desta Guma
JSJingshan Shen
Jingshan Shen
A ligand-free copper-catalyzed cyclization method is shown for synthesizing benzimidazoles and optimized process of benzimidazoles from cheap o-bromoarylamine and nitriles.

15 September 2023 in Organic Process Research & Development
Verified
Journal Article
Closed access
EBEMMANUEL MINTAH MINTAH BONKU
EMMANUEL MINTAH MINTAH BONKU
HQHongjian Qin
Hongjian Qin
AOAbdullajon Odilov
Abdullajon Odilov
FYFeipu Yang
Feipu Yang
XXXinglong Xing
Xinglong Xing
JSJingshan Shen
Jingshan Shen

20 December 2022 in Organic Process Research & Development
Verified
Journal Article
Closed access
HQHongjian Qin
Hongjian Qin
CJChen Jin
Chen Jin
AOAbdullajon Odilov
Abdullajon Odilov
EBEMMANUEL MINTAH MINTAH BONKU
EMMANUEL MINTAH MINTAH BONKU
FZFuqiang Zhu
Fuqiang Zhu
Haji Akber AisaHaji Akber Aisa
Haji Akber Aisa

2 December 2022 in ACS Omega
Verified
Journal Article
Open access
HQHongjian Qin
Hongjian Qin
AOAbdullajon Odilov
Abdullajon Odilov
EBEMMANUEL MINTAH MINTAH BONKU
EMMANUEL MINTAH MINTAH BONKU
FZFuqiang Zhu
Fuqiang Zhu
THTianwen Hu
Tianwen Hu
JSJingshan Shen
Jingshan Shen
A facile synthesis of benzimidazoles was described by a one-pot process containing acylation-cyclization of N-arylamidoxime. This method provided an alternative synthesis of benzimidazoles with a certain diversity of substituted groups in acceptable yields (up to 96%). More importantly, the construction of bis-benzimidazole (8), the key intermediate for making telmisartan, was achieved by adopting this method that enabled avoiding the undesired nitration with nitric/sulfuric acid and the cyclization in polyphosphoric acid in the existing operations.

11 October 2025 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
DWDaibao Wei
Daibao Wei
JGJinbo Guo
Jinbo Guo
FZFuqiang Zhu
Fuqiang Zhu
EBEMMANUEL MINTAH MINTAH BONKU
EMMANUEL MINTAH MINTAH BONKU
CSChangliang Sun
Changliang Sun
JSJingshan Shen
Jingshan Shen

2 May 2024 in Heliyon
Verified
Journal Article
Open access
EBEMMANUEL MINTAH MINTAH BONKU
EMMANUEL MINTAH MINTAH BONKU
HQHongjian Qin
Hongjian Qin
AOAbdullajon Odilov
Abdullajon Odilov
SASafomuddin Abduahadi
Safomuddin Abduahadi
SGSamuel Desta Guma
Samuel Desta Guma
JSJingshan Shen
Jingshan Shen
This article delineates the systematic identification, synthesis, and impurity control methods used during the manufacturing process development of tecovirimat, an antiviral drug that treats monkeypox. Critical impurities were synthesized, and their chemical structure was confirmed through NMR analysis, GC, and HPLC mass spectrometry. The results established a thorough approach to identify, address, and control impurities to produce high-quality tecovirimat drug substance in accordance with International Conference on Harmonization (ICH)-compliant standards. This study is the first of its kind to evaluate both process and genotoxic impurities in tecovirimat, demonstrating effective control measures during commercial sample investigations and scaling up to a 60-kg batch size. The findings highlight the importance of critical impurity characterization and control in pharmaceutical development and production to ensure the safety and efficacy of the final product.